4BIO Capital
Specialist life-sciences venture firm
VC
Sector Specialist
📍 London, United Kingdom
Founded 2014
AUM
Not Disclosed
Strategic / Balance-Sheet
PRIVATE
4BIO Capital is a London-based venture firm focused on biotech and precision therapies. The firm led Aptadir Therapeutics’ €40 million seed round announced September 29, 2026.
Investment Focus
Stages
Seed · Series A · Series B
Sectors
Biotech · Life Sciences · Therapeutics
VCLife SciencesEuropeDaily Discovery
Investor data reflects publicly disclosed AUM, fund sizes, and portfolio holdings as of recent date. Refreshed periodically.